Adherium Ltd. ( ($AU:ADR) ) has provided an update. Adherium has surpassed its key calendar year 2025 shipment targets for its Hailie Smartinhaler ...

Drug firm Cipla on Monday said it has launched orally inhaled insulin powder for diabetes patients in the country. The company had obtained regulatory approval from the Central Drugs Standard Control ...

Cipla had received regulatory approval from the Central Drugs Standard Control Organisation late last year for the exclusive ...

The insulin inhalation powder in Afrezza is available in single-use cartridges and is delivered via an inhaler device.

Drugmaker Cipla has launched Afrezza (insulin human) inhalation powder, the company said, about a year after the product got ...

Cipla has launched inhaled insulin powder in India, providing a needle-free alternative for diabetes patients. Approved by ...

Cipla has launched Afrezza, an inhaled rapid-acting insulin for adults with diabetes, after CDSCO approval, and plans an ...

Cipla launches Afrezza, an orally inhaled insulin powder for diabetes patients in India. A needle-free alternative to ...

Manufactured by Connecticut-based biopharmaceutical company MannKind Corporation, Afrezza was first launched in the United ...

Allied Market Research published a report, titled, 'Respiratory Inhaler Devices Market by Product (Metered Dose Inhalers, Dry ...

The global drug-device combination products market is projected to experience a compound annual growth rate (CAGR) of ...

Maryland lawmakers introduce the Affordable Inhalers and Nebulizers Act to reduce the cost of inhalers and expand Medicare ...